Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence CLISDFYPGAVTV
Primary information
sequence IDSeq_1031
Peptide sequenceCLISDFYPGAVTV
CancerPDF_ID CancerPDF_ID4479, CancerPDF_ID4480, CancerPDF_ID4481, CancerPDF_ID4482, CancerPDF_ID4483, CancerPDF_ID4484, CancerPDF_ID4485, CancerPDF_ID4486, CancerPDF_ID4487, CancerPDF_ID4488,
PMID24982608,24982608,24982608,24982608,24982608,24982608,24982608,24982608,24982608,24982608
Protein Name25 kDa protein,25 kDa protein,IGLat protein,IGLat protein,IGLat protein,IGLat protein,IGLat protein,IGLat protein,IGLat protein,Putative uncharacterized protein
UniprotKB Entry NameNA,NA,Q8N355_HUMAN,Q8N355_HUMAN,Q8N355_HUMAN,Q8N355_HUMAN,Q8N355_HUMAN,Q8N355_HUMAN,Q8N355_HUMAN,NA
FluidUrine,Urine,Urine,Urine,Urine,Urine,Urine,Urine,Urine,Urine
M/ZNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
ChargeNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Mass (in Da)NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
fdrNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Profiling TechniqueNano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS,Nano-LC-MS
Peptide Identification techniqueMS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS,MS/MS
Quantification TechniqueNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free,Label Free
FDR0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01,0.01
CancerPDF_ID CancerPDF_ID4479, CancerPDF_ID4480, CancerPDF_ID4481, CancerPDF_ID4482, CancerPDF_ID4483, CancerPDF_ID4484, CancerPDF_ID4485, CancerPDF_ID4486, CancerPDF_ID4487, CancerPDF_ID4488,
p-ValueNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Software"GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT","GPM search engine, MASCOT"
Length13,13,13,13,13,13,13,13,13,13
Cancer TypeOvarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer,Ovarian cancer
DatabaseIPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database ,IPI 3.71 Human Database
ModificationNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Number of Patients6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals,6 Ovarian cancer patients and 6 normal individuals
RegulationUniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients,Uniquely present in case of urine of ovarian cancer patients
ValidationNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
SensitivityNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
SpecificityNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
AccuracyNA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Peptide AtlasNA
IEDB